Warts Therapeutics Market Poised to Hit $2.36 Billion by 2029 with Accelerating Growth Trends

"Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Warts Therapeutics Market Size Growth Forecast: What to Expect by 2025?
The market size of warts therapeutics has seen a consistent growth in recent times. The market is projected to increase from a value of $1.96 billion in 2024 to approximately $2.01 billion in 2025, representing a compound annual growth rate (CAGR) of 2.6%. Factors such as the utilization of salicylic acid, advancements in cryotherapy, progression in topical treatments, surgical methods, and the introduction of immunotherapy have contributed to the growth observed in the historical period.

How Will the Warts Therapeutics Market Size Evolve and Grow by 2029?
The market size for warts therapeutics is anticipated to experience consistent expansion in the coming years. The market will reach ""$2.36 billion in 2029"", growing at a Compound Annual Growth Rate (CAGR) of 4.1%. This growth in the projected period can be credited to precision medicine for HPV, the advancement of laser therapy methods, the introduction of combination therapies, the rise of digital health remedies, and initiatives to make healthcare more accessible. The forecast period will also see major trends such as antiviral therapies that are targeted, research on gene editing, the development of biodegradable delivery systems, and a heightened focus on psychodermatology.

View the full report here:
https://www.thebusinessresearchcompany.com/report/warts-therapeutics-global-market-report

What Drivers Are Propelling the Growth of Warts Therapeutics Market Forward?
The wart therapeutics market is expected to flourish due to the heightened attention on wart vaccinations. Vaccinating involves administering a vaccine into the body to stimulate the formation of antibodies against infections and related diseases, such as those caused by the human papillomavirus (HPV), the virus responsible for warts. By using therapeutic or preventive vaccines against HPV, wart formation can be prevented. This growing concentration on wart vaccinations is positively influencing the sales in the wart therapeutics market. In a report by the World Health Organization in July 2023, a public health organization based in Switzerland, there was a notable decrease in ""zero-dose children"", children who haven't received any vaccinations, from 18.1 million in 2021 to 14.3 million in 2022. Moreover, the global coverage for the first dose of the HPV vaccine for girls escalated from 16% in 2021 to 21% in 2022. Consequently, the upward trend in wart vaccination focus promotes the growth of the wart therapeutics market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11959&type=smp

What Are the Key Trends Driving Warts Therapeutics Market Growth?
The wart therapeutics market is seeing a surge in popularity for product innovation trends. Companies within this market are gearing up with novel treatment methodologies to secure their market presence. For example, in February 2023, the American dermatology therapeutics firm, Verrica Pharmaceuticals Inc., disclosed that its refiled New Drug Application (NDA) for VP-102 - a remedy for molluscum* contagiosum (a wart variety) - was approved by the FDA (The United States Food and Drug Administration) with a designated Prescription Drug User Fee Act (PDUFA) number. This innovation, VP-102, is a patented combination of drug-device, which ensures the delivery of cantharidin (0.7% w/v) in a formulation controlled by good manufacturing practices (GMP) through a single-use applicator for exact topical dosing and targeted delivery.

What Are the Key Segments in the Warts Therapeutics Market?
The warts therapeutics market covered in this report is segmented -

1) By Type: Common Warts, Genital Warts, Flat Warts, Other Types
2) By Treatment: Physical Destruction, Immunomodulation, Chemical Destruction
3) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users

Subsegments:
1) By Common Warts: Typically Appear On Hands, Fingers, And Elbows, Caused By Human Papillomavirus (HPV) Types 2 And 4
2) By Genital Warts: Occur In The Genital And Anal Areas, Primarily Caused By HPV Types 6 And 11
3) By Flat Warts: Smaller And Smoother Than Common Warts, Commonly Found On The Face, Neck, And Arms
4) By Other Types: Includes Plantar Warts (On Feet) And Filiform Warts (Around The Mouth And Nose), Various HPV Types Can Cause These Warts

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=11959&type=smp

Who Are the Key Players Shaping the Warts Therapeutics Market's Competitive Landscape?
Major companies operating in the warts therapeutics market include GlaxoSmithKline plc, Merck & Co. Inc., Verrica Pharmaceuticals Inc., Bausch Health Companies Inc., Dr. Reddy's Laboratories Ltd, Cipla Inc., Prestige Consumer Healthcare Inc., Maruho Co. Ltd, Taro Pharmaceutical Industries Ltd, Aclaris Therapeutics Inc., Novan Inc, Scholl's Wellness Co, AIM ImmunoTech Inc., Euro Vital Pharma GmbH, Koninklijke Utermöhlen NV, Nielsen BioSciences Inc., RXi Pharmaceuticals, Phio Pharmaceuticals Corp., MedCara Pharmaceuticals, KinoPharma Inc., pHion Therapeutics, Compound W, Duofilm, Curad Mediplast, Emblation Ltd.

What Geographic Markets Are Powering Growth in the Warts Therapeutics Market?
North America was the largest region in the warts therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the warts therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11959

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Reach Out to Us
Speak With Our Expert:Saumya Sahay,
Americas +1 310-496-7795,
Asia +44 7882 955267 & +91 8897263534,
Europe +44 7882 955267,
Email: saumyas@tbrc.info
The Business Research Company - www.thebusinessresearchcompany.com
Follow Us On:LinkedIn: https://in.linkedin.com/company/the-business-research-company

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.